abstract |
The present invention utilizes a combination of compounds that alter soluble endoglin, endothelial nitric oxide synthase, PGI 2 , TGF-β1, TGF-β3, activin A, BMP2, BMP7 and sFlt-1 expression concentrations or biological activity. Methods for treating pregnancy-related hypertension diseases such as preeclampsia and preeclampsia are described. Also one or more of any; Soluble endoglin, endothelial nitric oxide synthase, PGI 2 , TGF-β1, TGF-β3, activin A, BMP2, BMP7 and sFlt-1 expression concentrations, including measurement of biological activity, such as preeclampsia and eclampsia Methods for diagnosing pregnancy-related hypertension diseases are described. |